⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

Bayer (Japan)

h-index: 51
Total citations: 9,362
Total papers: 407

Homepage: http://www.bayer.jp/english/index.html

Recent papers from Bayer (Japan)

WCN26-3652 Finerenone in Japanese Patients with Diabetic Kidney Disease: Insights from the J-DREAMS Real-World DatabaseKidney International Reports · 2026
Prediction of estimated glomerular filtration rate slope and kidney prognosis of patients with chronic kidney diseaseScientific Reports · 2026
Abstract DP297: Characteristics and Outcomes of the Real-World Cohort of Patients with Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack Compatible With the OCEANIC-STROKE Clinical Trial Population in JapanStroke · 2026
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trialJapanese Journal of Ophthalmology · 2025
Safety and efficacy of vilaprisan in Japanese women with fibroids: The Phase 3 ASTEROID 8 trialWomen s Health · 2025
Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer in Japan: The ARASHI StudyInternational Journal of Urology · 2025
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in AsiaClinical Journal of the American Society of Nephrology · 2025
Post-marketing surveillance of radium-223 chloride in Japanese patients with castration-resistant prostate cancer with bone metastasis—final analysis of 3-year extended follow-up focusing on bone fracturesInternational Journal of Clinical Oncology · 2025
Patient and physician preferences for cancer panel testing in Japan: a best-worst scaling studyBMJ Open · 2025
Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in JapanDiabetes Obesity and Metabolism · 2025
Do confined field trials add value for the environment risk assessment of genetically modified Brassica napus L. in Japan?Transgenic Research · 2025
Initial treatment and resource utilization among patients with metastatic-castration sensitive prostate cancer in Japan: a retrospective real-world studyJapanese Journal of Clinical Oncology · 2024
Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer PerspectiveAdvances in Therapy · 2024
The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patientsClinical and Experimental Nephrology · 2024
Triplet therapy for metastatic castration‐sensitive prostate cancer: Rationale and clinical evidenceInternational Journal of Urology · 2024
The health‐economic impact of urine albumin‐to‐creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetesJournal of Diabetes Investigation · 2024
Darolutamide in Japanese patients with metastatic hormone‐sensitive prostate cancer: Phase 3 ARASENS subgroup analysisCancer Medicine · 2024
Pharmacokinetics and pharmacodynamics of the factor XIa‐inhibiting antibody osocimab in healthy male East Asian volunteers: Results from two phase 1 studiesPharmacology Research & Perspectives · 2024
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) PlatformJournal of Clinical Medicine · 2024
Impact of EOB-MRI on the outcome of patients with pancreatic cancer in real-world settings.Journal of Clinical Oncology · 2024